The most common non-HLA antibodies were anti-ENO1 (28.4%), anti-FIBR1 (23.0%) and anti-PRKCZ (23.0%), indicating their possible involvement in the immune responses of patients with end-stage renal disease on the kidney transplant waiting list. This evidence concerns the gene ENO1 and chronic kidney disease.